Catalyst Health Stock Hits New 52-Week High (CHSI)

NEW YORK ( TheStreet) -- Catalyst Health Solutions (Nasdaq: CHSI) hit a new 52-week high Monday as it is currently trading at $92.63, above its previous 52-week high of $92.62 with 358,408 shares traded as of 1:30 p.m. ET. Average volume has been 833,500 shares over the past 30 days.

Catalyst Health has a market cap of $4.57 billion and is part of the technology sector and computer software & services industry. Shares are up 73.7% year to date as of the close of trading on Friday.

Catalyst Health Solutions, Inc. operates as a full-service pharmacy benefit management company primarily under the Catalyst Rx name in the United States. The company has a P/E ratio of 67.9, above the average computer software & services industry P/E ratio of 67.4 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Catalyst Health as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Catalyst Health Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.